Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
about
Differences in survival between Māori and New Zealand Europeans with prostate cancer.Treatment modalities for Māori and New Zealand European men with localised prostate cancer.Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.
P2860
Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Prostate-specific antigen (PSA ...... non-Māori men in New Zealand.
@ast
Prostate-specific antigen (PSA ...... non-Māori men in New Zealand.
@en
type
label
Prostate-specific antigen (PSA ...... non-Māori men in New Zealand.
@ast
Prostate-specific antigen (PSA ...... non-Māori men in New Zealand.
@en
prefLabel
Prostate-specific antigen (PSA ...... non-Māori men in New Zealand.
@ast
Prostate-specific antigen (PSA ...... non-Māori men in New Zealand.
@en
P2093
P2860
P356
P1433
P1476
Prostate-specific antigen (PSA ...... non-Māori men in New Zealand.
@en
P2093
Alistair Stewart
Charis Brown
Fraser Hodgson
Michael Holmes
Nina Scott
Ross Lawrenson
Zuzana Obertová
P2860
P2888
P356
10.1186/1471-2296-15-145
P577
2014-08-26T00:00:00Z
P5875
P6179
1033107313